SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-038533
Filing Date
2023-05-11
Accepted
2023-05-11 16:07:22
Documents
48
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_relmadatherap.htm   iXBRL 10-Q 379547
2 CERTIFICATION f10q0323ex31-1_relmadatherap.htm EX-31.1 11565
3 CERTIFICATION f10q0323ex31-2_relmadatherap.htm EX-31.2 11016
4 CERTIFICATION f10q0323ex32-1_relmadatherap.htm EX-32.1 4805
5 CERTIFICATION f10q0323ex32-2_relmadatherap.htm EX-32.2 4322
  Complete submission text file 0001213900-23-038533.txt   2812232

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rlmd-20230331.xsd EX-101.SCH 36561
7 XBRL CALCULATION FILE rlmd-20230331_cal.xml EX-101.CAL 24104
8 XBRL DEFINITION FILE rlmd-20230331_def.xml EX-101.DEF 156483
9 XBRL LABEL FILE rlmd-20230331_lab.xml EX-101.LAB 334025
10 XBRL PRESENTATION FILE rlmd-20230331_pre.xml EX-101.PRE 169090
42 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_relmadatherap_htm.xml XML 212954
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39082 | Film No.: 23910995
SIC: 2834 Pharmaceutical Preparations